{"id":93120,"date":"2019-07-04T10:03:09","date_gmt":"2019-07-04T17:03:09","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2019\/07\/an-interview-with-sergey-young"},"modified":"2019-07-04T10:03:09","modified_gmt":"2019-07-04T17:03:09","slug":"an-interview-with-sergey-young","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2019\/07\/an-interview-with-sergey-young","title":{"rendered":"An Interview with Sergey Young"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/an-interview-with-sergey-young2.jpg\"><\/a><\/p>\n<p>My colleague Nicola Bagal\u00e0 recently had the opportunity to interview Sergey Young, a board member of XPRIZE and the creator of the $100m Longevity Vision Fund. As you probably know, at the end of May this year XPrize hosted a 2-day workshop to better understand the bottlenecks and opportunities of the longevity industry, and in this interview, Sergey is sharing his vision on what can \u2014 and should \u2014 be done to accelerate the development of new therapies addressing aging.<\/p>\n<hr>\n<p>We recently had the opportunity to interview Sergey Young, a board member of XPRIZE and the creator of the $100m <a href=\"https:\/\/lvf.vc\/\"> Longevity Vision Fund<\/a>.<\/p>\n<p><strong>When did you first become interested in healthy life extension, and why?<\/strong><\/p>\n<p>My interest began with a routine visit to a doctor. Five years ago, at the age of 42, my blood tests \u2013 which I neglected for 7 years, thinking I was in perfect health \u2013 showed that my cholesterol was extremely high, putting me at risk of one of the most common killers: heart disease.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>My colleague Nicola Bagal\u00e0 recently had the opportunity to interview Sergey Young, a board member of XPRIZE and the creator of the $100m Longevity Vision Fund. As you probably know, at the end of May this year XPrize hosted a 2-day workshop to better understand the bottlenecks and opportunities of the longevity industry, and in [\u2026]<\/p>\n","protected":false},"author":511,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,269],"tags":[],"class_list":["post-93120","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-life-extension"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/93120","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/511"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=93120"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/93120\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=93120"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=93120"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=93120"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}